The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A theranostic approach: Imaging and therapy of delta-like ligand 3–expressing small cell lung cancers.
 
Salomon Tendler
No Relationships to Disclose
 
Tran T Hoang
No Relationships to Disclose
 
David Bauer
No Relationships to Disclose
 
Alexa Michel
No Relationships to Disclose
 
Roberto Degregorio
No Relationships to Disclose
 
Lukas Carter
No Relationships to Disclose
 
Nagavarakishore Pillarsetty
Stock and Other Ownership Interests - Abbvie; Amedisys; Bayer; Celldex; Editas Medicine; GE Healthcare; Genentech; Ionis Pharmaceuticals; Johnson & Johnson; Lexicon; Madrigal Pharmaceuticals; OncoMed; Quaero Pharmaceuticals; Verastem; Viking Therapeutics; Y-mAbs Therapeutics; ZIOPHARM Oncology
Patents, Royalties, Other Intellectual Property - Adjuvance; Quaero Pharmaceuticals; Samus Therapeutics
 
John T. Poirier
Patents, Royalties, Other Intellectual Property - Takeda
 
Jason Stuart Lewis
Leadership - Clarity Pharmaceuticals; Evergreen Theragnostics; pHLIP; Telix Pharmaceuticals
Stock and Other Ownership Interests - Clarity Pharmaceuticals; Evergreen Theragnostics; pHLIP; Telix Pharmaceuticals
Consulting or Advisory Role - Clarity Pharmaceuticals; Evergreen Theragnostics; pHLIP; Telix Pharmaceuticals
Research Funding - AVID Radiopharmaceuticals; Clarity Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Daiichi Sankyo; DiaProst; Theragnostics
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bridge Medicines; Daiichi Sankyo/UCB Japan; Earli; Epizyme; Genentech/Roche; Harpoon Therapeutics; Ipsen; Jazz Pharmaceuticals; Kowa; Merck; Syros Pharmaceuticals; Syros Pharmaceuticals
Research Funding - Merck (Inst); Roche/Genentech (Inst)